Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates
- 31 July 1992
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 110 (1-2) , 222-227
- https://doi.org/10.1016/0022-510x(92)90031-f
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Synthesis of azabicyclic pyrazine derivatives as muscarinic agonists and the preparation of a chloropyrazine analogue with functional selectivity at sub-types of the muscarinic receptorJournal of the Chemical Society, Chemical Communications, 1991
- Phase 1 study of FKS-508-singie and multiple dose studiesEuropean Journal of Pharmacology, 1990
- Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysisNeuroscience Letters, 1990
- Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102BPharmacology Biochemistry and Behavior, 1990
- Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesiaBrain Research, 1990
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated ratsNeuroscience Letters, 1989
- No response to high‐dose muscarinic agonist therapy in Alzheimer's diseaseNeurology, 1988
- RS 86 in the treatment of alzheimer's disease: Cognitive and biological effectsBiological Psychiatry, 1987
- The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonistEuropean Journal of Pharmacology, 1986